Bolt Biotherapeutics, Inc. (BOLT) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$39.85M | +35.0% |
| 2024 | -$61.29M | +11.8% |
| 2023 | -$69.53M | +9.1% |
| 2022 | -$76.50M | -34.1% |
| 2021 | -$57.07M | -20.6% |
| 2020 | -$47.31M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$39.85M | +35.0% |
| 2024 | -$61.29M | +11.8% |
| 2023 | -$69.53M | +9.1% |
| 2022 | -$76.50M | -34.1% |
| 2021 | -$57.07M | -20.6% |
| 2020 | -$47.31M | — |